INSM

INSMED INC

INSM·457669307·US·Common Stock·Healthcare - Biotechnology-13D/G

INSM (INSMED INC) is held by 276 institutional investors as of Q1 2026. Largest holders: JPMORGAN CHASE & CO ($3.7B), BlackRock, Inc. ($2.7B), FMR LLC ($2.2B). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 165 funds bought INSM.

276
Holders
(19 Elite)
$29.8B
Total Value
57% (287)
Consensus
165 buying - 122 selling
13F: Insider & Congress:
INSMSmart Money Verdict
View all
Held by 276 funds
19 elite
Who's Trading
InsiderLWLewis WilliamSell $583KJul 9, 2026
InsiderLWLewis WilliamSell $275KJul 9, 2026
InsiderLWLewis WilliamSell $398KJul 9, 2026
InsiderFMFlammer Martina M.D.Sell $529KJul 6, 2026
CongressJosh GottheimerJosh GottheimerSale $1,001 - $15,000Jun 10, 2026
ActivistDGDarwin Global Management, Ltd.7.8%May 15, 2026
ActivistFMR LLCFMR LLC6.1%May 6, 2026
CongressGilbert CisnerosGilbert CisnerosSale $1,001 - $15,000Oct 3, 2025
CongressGilbert CisnerosGilbert CisnerosSale $1,001 - $15,000Sep 22, 2025
CongressGilbert CisnerosGilbert CisnerosSale $1,001 - $15,000Aug 8, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
24.2M(+4.1%)$3.7B0.2%+7.18%
40
Increased
16.7M(+10.7%)$2.7B0.0%+17.01%
35
Increased
13.2M(+32.6%)$2.2B0.1%-4.13%
49
New
10.4M$1.7B0.1%-21.35%
44
New
9.6M$1.6B0.0%-21.35%
44
Increased
7.4M(+12.6%)$1.2B7.0%+37.92%
70
Increased
6.5M(+34.8%)$1.1B1.7%+8.18%
65
Increased
5.6M(+29.3%)$919.9M0.6%-3.75%
56
Increased
5.6M(+8.6%)$914.9M0.2%+70.17%
41
Increased
5.6M(+6.7%)$907.8M0.0%+50.17%
34
Increased
4.8M$791.9M7.9%+25.40%
61
Increased
4.5M(+3.5%)$733.3M0.0%+76.89%
33
Decreased
3.1M(-23.4%)$505.7M0.1%+304.15%
0
Increased
3.1M(+55.3%)$500M0.1%+56.95%
53
Decreased
2.6M(-5.0%)$428M0.1%+85.61%
0
Increased
2.2M(+88.6%)$356.9M0.1%-4.50%
49
Decreased
2M(-27.1%)$325.2M0.0%+14.49%
0
Decreased
1.9M(-55.2%)$306.2M1.3%-13.39%
0
Decreased
1.7M(-7.0%)$284.1M0.0%-11.84%
0
Decreased
1.5M(-12.9%)$245.7M0.0%+23.76%
0

Showing 1-20 of 292

1 / 15

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used